|
NSA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.875800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.266400E-01 |
| Normal-vs-Stage2 |
1.039630E-01 |
| Normal-vs-Stage3 |
7.342800E-01 |
| Normal-vs-Stage4 |
1.947770E-02 |
| Stage1-vs-Stage2 |
2.239400E-01 |
| Stage1-vs-Stage3 |
8.199000E-01 |
| Stage1-vs-Stage4 |
8.143400E-03 |
| Stage2-vs-Stage3 |
1.942990E-01 |
| Stage2-vs-Stage4 |
1.447200E-01 |
| Stage3-vs-Stage4 |
7.801000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.599000E-01 |
| Normal-vs-AfricanAmerican |
6.512300E-02 |
| Normal-vs-Asian |
2.600400E-01 |
| Caucasian-vs-AfricanAmerican |
1.000790E-01 |
| Caucasian-vs-Asian |
1.535370E-01 |
| AfricanAmerican-vs-Asian |
5.578600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.607200E-01 |
| Normal-vs-Female |
3.812300E-02 |
| Male-vs-Female |
2.532300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.685200E-01 |
| Normal-vs-Extreme_Weight |
6.127000E-01 |
| Normal-vs-Obese |
7.423700E-02 |
| Normal-vs-Extreme_Obese |
9.550600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.781200E-01 |
| Normal_Weight-vs-Obese |
2.357200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.898000E-01 |
| Extreme_Weight-vs-Obese |
1.550570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.649800E-01 |
| Obese-vs-Extreme_Obese |
3.606600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.868600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.640200E-02 |
| Normal-vs-Age(61-80Yrs) |
8.548600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.057600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.856800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.360000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.181800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.251800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.334200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.732000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.677800E-01 |
| Normal-VS-Type2 PRCC |
6.257800E-02 |
| Normal-VS-KIRP CIMP |
4.651000E-01 |
| Normal-VS-Unclassified PRCC |
5.135800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.768400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.093200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.476400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.785400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.453400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.701600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.955600E-01 |
| Normal-vs-N1 |
4.113600E-02 |
| Normal-vs-N2 |
6.311800E-02 |
| N0-vs-N1 |
2.033600E-01 |
| N0-vs-N2 |
4.561400E-01 |
| N1-vs-N2 |
8.688400E-01 |
|
|
